Paris, Ile-de-France, France Conseil Plus Gestion appeared to be the Corporate Investor, which was created in 1999. The fund was located in Europe if to be more exact in France. The main office of represented Corporate Investor is situated in the Paris.
The important activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Therapixel. We can highlight the next thriving fund investment areas, such as Software, Medical Device.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Conseil Plus Gestion, startups are often financed by Demeter Partners, Paca Investissement, Sofimac Partners. The meaningful sponsors for the fund in investment in the same round are Paca Investissement, Sofimac Partners, IT-Translation. In the next rounds fund is usually obtained by Paca Investissement, Amundi Private Equity Funds, Sofimac Partners.
Related Funds
| Fund Name | Location |
| Clariant | Basel-Landschaft, Muttenz, Switzerland |
| DZW Capital | - |
| Highway One Capital | - |
| Jack W. Schuler Living Trust | - |
| Raba | Cape Town, South Africa, Western Cape |
| Reliant Energy | Houston, Texas, United States |
| Sigma Prime Ventures | Boston, Massachusetts, United States |
| UNIVA Paycast | Chiyoda, Japan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Therapixel | $708K | 24 Nov 2015 | Provence-Alpes-Côte d'Azur | ||
In’Oya | $507K | 29 Jan 2015 | Provence-Alpes-Côte d'Azur |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Therapixel | $708K | 24 Nov 2015 | Provence-Alpes-Côte d'Azur | ||
In’Oya | $507K | 29 Jan 2015 | Provence-Alpes-Côte d'Azur |
